The Fungal Disease Surveillance and Capacity
Project

Building Fungal Disease Surveillance Capacity in the Southern African Region.

The Fungal Disease Surveillance and Capacity
Project

Building Fungal Disease Surveillance Capacity in the Southern African Region.

Project Overview

The Fungal Disease Surveillance and Capacity in the Southern African Region project is a regional initiative led by the Wits Mycology Division and Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses (CHARM) at the National Institute for Communicable Diseases (NICD), South Africa, in collaboration with national public health institutes and laboratories across multiple Southern African countries. The project aims to strengthen surveillance systems for priority fungal diseases—such as cryptococcal meningitis, histoplasmosis, and candidemia—through capacity building, technical support, and improved laboratory diagnostics. By developing standardized surveillance protocols, enhancing laboratory capacity, and facilitating data sharing across countries, the project seeks to provide accurate regional estimates of disease burden, improve case detection, and inform public health interventions.

Key Objectives

Primary goals and focus areas of the project
  • Increase and improve cross-border detection and surveillance of fungal pathogens in southern Africa.
  • Understand the epidemiology and aetiology of invasive fungal diseases (known, re-emerging & novel).
  • Exploit genomic epidemiology to characterise outbreaks caused invasive fungal pathogens; track changes in disease patterns; understand the transmission dynamics in acute and long-term healthcare settings & community.
  • Understand pathogens in terms of their ecological niche, potential to cause clusters or outbreaks, virulence, detection by conventional laboratory methods and antifungal resistance.
  • Support antimicrobial resistance and HIV/AIDS regional and national strategies.
  • To ultimately improve public health for patients in healthcare facilities and PLWH; and improve clinical outcomes for those with confirmed fungal diseases.

Achievements

The Fungal Disease Surveillance and Capacity Project has made significant strides in strengthening regional capacity for fungal diagnostics and surveillance. At least one scientist from each of the nine participating Southern African countries has been trained in medical mycology, including fungal culture identification and antifungal susceptibility testing. The project has successfully initiated point prevalence surveys (PPS) in seven countries—Mozambique, Botswana, Zambia, Zimbabwe, Angola, Namibia, and Lesotho—providing much-needed baseline data on the burden of fungal infections. Notably, Candida auris was identified for the first time in Botswana and Mozambique through laboratory surveillance, and in Zimbabwe through the implementation of optimized wastewater surveillance protocols. Wastewater surveillance, now implemented in South Africa, Mozambique, and Zimbabwe, has proven to be an innovative and effective tool for early detection of high-priority fungal pathogens. Furthermore, the project has strengthened genomic surveillance capacity by training four scientists in fungal whole genome sequencing and bioinformatics, including the use of tools such as FungiPhylogen for phylogenetic analysis and antifungal resistance detection.

Current Status

Malawi

We have received ethics approval for Malawi and completed the point prevalence survey (PPS).

Eswatini

We are still awaiting ethics approval for Eswatini, with the aim of initiating activities before the end of Budget Period 4 in September.

Mozambique

We are preparing to launch a prospective cohort study in Mozambique, where the first Candida auris case was identified. This study will focus on documenting Candida colonization—particularly multidrug-resistant (MDR) strains—throughout the course of patient ICU admissions. It will also include antifungal consumption tracking at the ICU and hospital levels, and an evaluation of antifungal stewardship (AFS) and infection prevention and control (IPC) practices. Serial patient swabs, blood cultures, environmental sampling, and whole genome sequencing (WGS) will be conducted to assess colonization, resistance patterns, and transmission dynamics, while antifungal prescribing data will support targeted stewardship interventions.

Recruitment / Site Participation

  • Recruitment targets vs. actuals (for live recruitment graph).
  • Timeline trends and progress by site or province.
  • List of active, onboarding, and completed sites.
CountryPartners TrainedSite Visit ConductedLocal Approvals ObtainedPPS CompletedPPS Results Shared
Angola
Mozambique
Zambia
Zimbabwe
Namibia
Botswana
Lesotho
Malawi
Eswatini

Media

Fungal Disease Surveillance and Capacity in the Southern Africa Region

Publications and Abstracts

International Congress on Infectious Diseases (ICID)

Sergio Massora, Chalwe Sokoni, and Teresia Gatonye attended the International Congress on Infectious Diseases (ICID) held in Cape Town in 2024.

ESCMID Global Congress

Miriam Mwamba participated in the ESCMID Global Congress in Vienna, Austria, in 2025.

ISHAM Congress

Rudzani Mashau and Silondiwe Nzimande are scheduled to attend the ISHAM Congress in Iguaçu, Brazil

Events

June – July 2025

The project plans to train at least four scientists from the region in fungal genome sequencing analysis during June and July.